Literature DB >> 7068926

Medical audit of rectal biopsy diagnosis of inflammatory bowel disease.

J V Frei, B C Morson.   

Abstract

The records of the rectal biopsy diagnoses of ulcerative colitis and Crohn's disease in the Department of Pathology, St Mark's Hospital, London, were reviewed. The biopsy diagnoses were compared to subsequent resection diagnoses on the same patients, and annual and seasonal variations in the frequency of these and related diagnoses were studied. The accuracy rate for the biopsy diagnosis of ulcerative colitis was about 70% and for Crohn's disease about 40% each time a biopsy was read. The low figure for the accuracy rate for Crohn's disease could be attributed to sampling error inherent in the diagnosis of a disease which is essentially patchy, showing discontinuous pathology. Also, many patients with Crohn's disease have a normal rectum which is biopsied to demonstrate the distinction from ulcerative colitis. In practical terms therefore a 40% accuracy rate in Crohn's disease is probably adequate. The rate of "false-positive" diagnoses was about 5%. There was a seasonal variation in the frequency of these two diagnoses, but no variation attributable to changes in observers, as pathology trainees in the Department change regularly. The frequency of diagnoses of non-specific inflammation and of normal colon did show such non-random variations.

Entities:  

Mesh:

Year:  1982        PMID: 7068926      PMCID: PMC497543          DOI: 10.1136/jcp.35.3.341

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  2 in total

1.  Cost-benefit and cost-effectiveness analysis in health care. Growth and composition of the literature.

Authors:  K E Warner; R C Hutton
Journal:  Med Care       Date:  1980-11       Impact factor: 2.983

2.  Pathology of inflammatory bowel disease.

Authors:  B C Morson
Journal:  Gastroenterol Jpn       Date:  1980-04
  2 in total
  9 in total

1.  Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications.

Authors:  C A Seldenrijk; B C Morson; S G Meuwissen; N W Schipper; J Lindeman; C J Meijer
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

2.  Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative.

Authors:  D Jenkins; M Balsitis; S Gallivan; M F Dixon; H M Gilmour; N A Shepherd; A Theodossi; G T Williams
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

3.  A study of the histological criteria for ulcerative colitis: retrospective evaluation of multiple colonic biopsies.

Authors:  Y Konuma; M Tanaka; H Saito; A Munakata; Y Yoshida
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

4.  An external quality assessment scheme in histopathology.

Authors:  A J Sherwood; A C Hunt
Journal:  J Clin Pathol       Date:  1984-04       Impact factor: 3.411

5.  Observer variation and discriminatory value of biopsy features in inflammatory bowel disease.

Authors:  A Theodossi; D J Spiegelhalter; J Jass; J Firth; M Dixon; M Leader; D A Levison; R Lindley; I Filipe; A Price
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

6.  Quality assurance and medical audit in histopathology.

Authors:  B C Morson
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

7.  Histopathology reporting of mastectomy specimens--an assessment of inter-hospital variation.

Authors:  J D van der Walt; S I Baithun; C L Berry
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

8.  "Medical audit of rectal biopsy diagnosis of inflammatory bowel disease" is not medical audit.

Authors:  D N Baron
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

9.  Audit of the histopathological diagnosis of non-neoplastic colorectal biopsies: achievable standards for the diagnosis of inflammatory bowel disease.

Authors:  A K Dube; S S Cross; A J Lobo
Journal:  J Clin Pathol       Date:  1998-05       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.